LeonaBio, Inc. Earnings Per Share (Basic)
LeonaBio, Inc. (LONA) reported Earnings Per Share (Basic) of -$0.80 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- LeonaBio, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.80.
- LeonaBio, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$1.73.
- LeonaBio, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$15.58.
- LeonaBio, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$1.68.
- LeonaBio, Inc. earnings per share, basic for fiscal 2025 was -$24.70.
- LeonaBio, Inc. earnings per share, basic for fiscal 2024 was -$25.19.
- LeonaBio, Inc. earnings per share, basic for fiscal 2023 was -$3.09.
- LeonaBio, Inc. earnings per share, basic for fiscal 2022 was -$2.53.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.80 10-Q · filed 2026-08-14 | -$2.43 10-Q · filed 2026-08-14 | -$8.43 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$10.90 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2026-03-31 | -$1.73 10-Q · filed 2026-05-07 | -$9.54 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$13.01 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$16.11 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-12-31 | -$15.58 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$19.35 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$22.02 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$24.70 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$1.68 10-Q · filed 2025-11-06 | -$3.46 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$5.80 10-Q · filed 2025-11-06 | -$9.67 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||||
| 2025-06-30 | -$1.78 10-Q · filed 2026-08-14 | -$0.18 10-Q · filed 2025-08-07 | -$4.12 10-Q · filed 2026-08-14 | -$0.41 10-Q · filed 2025-08-07 | -$8.00 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$15.43 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||
| 2025-03-31 | -$2.34 10-Q · filed 2026-05-07 | -$0.23 10-Q · filed 2025-05-09 | -$6.23 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$13.66 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$6.38 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||
| 2024-12-31 | -$3.89 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$11.35 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$4.60 derived: net income ÷ weighted average shares · filed 2026-05-11 | -$25.19 10-K · filed 2026-03-31 | -$2.52 10-K · filed 2025-02-27 | |||
| 2024-09-30 | -$7.46 10-Q · filed 2025-11-06 | -$0.75 10-Q · filed 2024-11-07 | -$2.63 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$21.33 10-Q · filed 2025-11-06 | -$2.13 10-Q · filed 2024-11-07 | -$3.68 derived: net income ÷ weighted average shares · filed 2025-11-06 | ||
| 2024-06-30 | -$0.70 10-Q · filed 2025-08-07 | -$1.39 10-Q · filed 2025-08-07 | -$2.10 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$2.97 derived: net income ÷ weighted average shares · filed 2025-11-06 | ||||
| 2024-03-31 | -$0.69 10-Q · filed 2025-05-09 | -$1.40 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$2.27 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$3.05 derived: net income ÷ weighted average shares · filed 2025-11-06 | ||||
| 2023-12-31 | -$0.72 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$1.58 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$2.36 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$3.09 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | -$0.87 10-Q · filed 2024-11-07 | -$1.65 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$2.38 10-Q · filed 2024-11-07 | -$3.18 derived: net income ÷ weighted average shares · filed 2024-11-07 | ||||
| 2023-06-30 | -$0.78 10-Q · filed 2024-08-01 | -$1.51 10-Q · filed 2024-08-01 | -$2.31 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$2.84 derived: net income ÷ weighted average shares · filed 2024-11-07 | ||||
| 2023-03-31 | -$0.73 10-Q · filed 2024-05-15 | -$1.53 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$2.06 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$2.71 derived: net income ÷ weighted average shares · filed 2024-11-07 | ||||
| 2022-12-31 | -$0.80 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$1.33 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$1.98 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$2.53 10-K · filed 2024-02-22 | ||||
| 2022-09-30 | -$0.53 10-Q · filed 2023-11-09 | -$1.18 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.74 10-Q · filed 2023-11-09 | -$2.18 derived: net income ÷ weighted average shares · filed 2023-11-09 | ||||
| 2022-06-30 | -$0.65 10-Q · filed 2023-08-10 | -$1.20 10-Q · filed 2023-08-10 | -$1.64 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.06 derived: net income ÷ weighted average shares · filed 2023-11-09 | ||||
| 2022-03-31 | -$0.56 10-Q · filed 2023-05-11 | -$1.00 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.42 derived: net income ÷ weighted average shares · filed 2023-11-09 | |||||
| 2021-12-31 | -$0.44 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$0.86 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$1.49 10-K · filed 2023-03-23 | |||||
| 2021-09-30 | -$0.42 10-Q · filed 2022-11-10 | -$1.05 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |